Andrew Ewald is an Associate Professor of Cell Biology, Oncology, and Biomedical Engineering in the Department of Cell Biology at Johns Hopkins University School of Medicine for Cell Dynamics. He also has secondary appointments in the Sidney Kimmel Comprehensive Cancer Center and Department of Oncology. He received his BS from Haverford College, his PhD from California Institute of Technology, and his postdoctoral training from the University of California San Francisco.
Dr. Ewald received his undergraduate degree in physics with honours from Haverford College. He earned his Ph.D. in biochemistry and molecular physics from the California Institute of Technology. He completed postdoctoral work with Zena Werb in mammary biology and cancer at the University of California, San Francisco. Dr. Ewald joined the Johns Hopkins faculty in 2008.
He is a member of the American Association for Cancer Research, Society for Developmental Biology, and the American Society for Cell Biology. His work was recognized with the 2011 Morphological Sciences Award from the American Association of Anatomists for his contributions to the field of epithelial morphogenesis.
Dr. Ewalds investigation line is focused on cellular and molecular mechanisms of epithelial growth, invasion and metastasis; how clusters of cancer cells disseminate from the tumor, traverse the systemic circulation, and cooperate with resident stromal cells to colonize distant organs. His studies show how cells build organs and how these same cellular processes can contribute to breast cancer metastasis. Dr. Ewald’s research lab identified a unique class of breast cancer cells that lead the process of invasion into surrounding tissues—a first step in cancer metastasis. Further research is planned to examine if these cells are viable targets for therapy. His research group seeks to understand how cells build organs and how these same cellular processes can contribute to cancer metastasis.
The Institute for NanoBioTechnology (INBT) at Johns Hopkins University is an exceptionally diverse, multidisciplinary team of faculty, researchers, and student experts uncovering new knowledge and creating innovative technologies at the interface of nanoscience, engineering, biology, and medicine. Launched in 2006, INBT aims to revolutionize research by fostering a collaborative environment among engineers, scientist, and clinicians to pioneer new ways to solve some of the most complex challenges in healthcare and the environment.